Medicilon Logo
search icon search icon language icon contact icon menu icon
Medicilon Logo
search icon close search icon language icon contact icon menu icon
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
Hybridoma Technology

Hybridoma Technology

Medicilon's biology department has established an antibody drug development platform, and our team members have more than 10 years experience in custom antibody production. Medicilon's hybridoma R&D services can provide a variety of immunization methods (proteins, peptides, small molecules, whole cells) to meet with the client's needs.
Development Process of Hybridoma Technology Platform
  • Development Process of Hybridoma Technology Platform
Experimental Timeline
    • 01
      Antigen preparation (provided by the customer or Medicilon)
    • new icon

    • 02
      Standard immunization and serum titer testing
      6-8 weeks
    • new icon

    • 03
      Fusion screening subclones
      4-6 weeks
    • new icon

    • 04
      Providing antibody sequence
      2 weeks
Service Advantage
  • Accredited animal facilities:full AAALAC certification; Multiple Immunization methods: Medicilon offers various antigen immunization schemes such as protein, peptide, VLP, whole cell and DNA for antigen preparation; High-throughput screening: FACS, ELISA workstation, Biacore affinity, etc., with high screening efficiency; Comprehensive functional testing services:The functional verification testing platform provides in-vitro pharmacodynamic testing services such as Affinity Ranking, Affinity Measurement, EC50 and IC50, and Cross-reactivity; etc.
Advanced Equipment
  • Hybridoma Technology Advanced Equipment-High throughput screening
    Hybridoma Technology Advanced Equipment-Elisa and Flow Cytometry
    Hybridoma Technology Advanced Equipment-AKTA purification
    Hybridoma Technology Advanced Equipment-Animal immunity: SPF animal lab
Relevant articles